BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16361126)

  • 21. Lymphoma: an update on evolving trends in staging and management.
    Dailey SH; Sataloff RT
    Ear Nose Throat J; 2001 Mar; 80(3):164-70. PubMed ID: 11269220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
    Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
    Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
    Czernin J; Allen-Auerbach M; Schelbert HR
    J Nucl Med; 2007 Jan; 48 Suppl 1():78S-88S. PubMed ID: 17204723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tumor search with diffusion-weighted imaging--first experience].
    Bohlscheid A; Nuss D; Lieser S; Busch HP
    Rofo; 2008 Apr; 180(4):302-9. PubMed ID: 18370348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A staging of lymphomas: practical thoughts on impractical practices.
    Raubitschek A; Goffman T; Glatstein E
    J Natl Cancer Inst Monogr; 1990; (10):13-7. PubMed ID: 2346707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant lymphoma: therapy and assessment of the course].
    Delorme S
    Radiologe; 2012 Apr; 52(4):320. PubMed ID: 22454099
    [No Abstract]   [Full Text] [Related]  

  • 30. [Response criteria for malignant lymphoma].
    Ganten MK
    Radiologe; 2012 Apr; 52(4):330-7. PubMed ID: 22418972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thoracic Imaging Manifestations of Treated Lymphomas: Response Evaluation, Posttherapeutic Sequelae, and Complications.
    Gooch CR; Jain MK; Petranovic M; Chow DZ; Muse VV; Gagne SM; Wu CC; Stowell JT
    J Thorac Imaging; 2022 Mar; 37(2):67-79. PubMed ID: 35191861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravascular Lymphoma.
    Sureka B; Bansal K; Arora A
    AJR Am J Roentgenol; 2015 Sep; 205(3):W387. PubMed ID: 26295679
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to "Intravascular Lymphoma".
    Chauhan A
    AJR Am J Roentgenol; 2015 Sep; 205(3):W388. PubMed ID: 26295680
    [No Abstract]   [Full Text] [Related]  

  • 34. The ultimate generalist: Miss Havisham is ill.
    Stevens R
    Br J Gen Pract; 2015 Feb; 65(631):82. PubMed ID: 25624289
    [No Abstract]   [Full Text] [Related]  

  • 35. Good, Better, or Best - What to Choose?
    Kobo O; Roguin A
    Cardiovasc Revasc Med; 2021 Aug; 29():97-99. PubMed ID: 32900642
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters.
    Nguyen TNA; Huang PS; Chu PY; Hsieh CH; Wu MH
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging and cancer: a review.
    Fass L
    Mol Oncol; 2008 Aug; 2(2):115-52. PubMed ID: 19383333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of imaging to choose treatment.
    Fermé C; Vanel D; Ribrag V; Girinski T
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S113-9. PubMed ID: 16361126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anatomic and functional imaging in the management of lymphoma.
    Al-Nahhas A; Win Z; Al-Sayed Y; Khan S; Singh A; Rubello D; Gishen P
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):251-9. PubMed ID: 17538524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.